Menovazan Pro painkiller patch No. 5

Instructions for Menovazan Pro Pain Relief Patch No. 5

Composition

Hydrogel base, non-woven material, polypropylene film.

Active ingredient: racemic menthol – 0.25 g (g)

Excipients: meloxicam 0.1 g (g), procaine hydrochloride 0.1 g (g), benzocaine 0.1 g (g).

Properties

Menovazan PRO is a medical device intended for topical use and its properties are due to the action of active ingredients. In particular, due to the selective action of menthol on cold receptors, the patch causes a feeling of cold, and the irritating effect can be replaced by slight anesthesia. Menthol reflexively changes the tone of blood vessels. This applies to both superficial vessels and vessels located deeper. Meloxicam penetrates the skin, reaching the subcutaneous tissues, and has an analgesic, anti-inflammatory effect, reduces tissue swelling. Procaine hydrochloride has anesthetic activity. It does not change the tone of blood vessels. Benzocaine causes superficial anesthesia.

Indications for use

Local temporary anesthesia:

inflammation of tendons, ligaments, muscles and joints of traumatic etiology, for example, with sprains of ligaments and tendons, dislocations, bruises;

localized forms of rheumatism of soft tissues and joints.

Method of administration and doses

The patch is applied to the affected area of the body. Apply 1 patch 2 times a day, morning and evening. The patch cannot be divided.

Do not use the patch with an occlusive dressing.

One patch is designed for continuous use for 12 hours.

Only 1 patch can be applied to one area at a time.

The maximum daily dose is 2 patches, even if it is necessary to apply the patch to more than one area.

The duration of use of the medical product should not exceed 7 days.

Application procedure:

Before use, remove the transparent film that protects the surface of the patch.

If necessary, the patch is fixed with an elastic bandage.

The duration of use of the medical product should not exceed 7 days.

Application features

Use during pregnancy or breastfeeding:

Do not apply.

Use with caution in patients with impaired renal, cardiac or hepatic function, with a history of gastric and duodenal ulcers, intestinal phlegmon or hemorrhagic diathesis.

Children

Do not use in children under 18 years of age.

Side effect

Allergic reactions are possible (including hyperemia, skin irritation, itching, rash, edema, urticaria), contact dermatitis.

Contraindication

Hypersensitivity to the active substance or to any other substance included in the composition.

History of attacks of bronchial asthma, urticaria or acute rhinitis caused by taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs.

Exacerbation of gastric and duodenal ulcers, open skin lesions, burns, skin infections or eczema.

Open skin lesions, burns, skin infections or eczema.

Reservation

If any skin rash appears after applying the patch, you should stop using it.

The patch should not be applied to open wounds (e.g. scratches, cuts) or eczematous areas of the skin. Avoid contact with eyes and mucous membranes.

Elderly patients should use NSAIDs with caution due to a greater susceptibility to side effects.

In patients with a history of allergy or bronchial asthma, bronchospasm may occur when using NSAIDs.

Direct sunlight or tanning bed exposure to the patch application site should be avoided for approximately 1 day to reduce the risk of photosensitivity.

Release form

1 patch per packet, 5 packets per box.

Expiration date

3 years.

The expiration date is indicated on the box.

Storage conditions

Store at a temperature of 2°C to 25°C out of the reach of children.